ANA
VILLEGAS MARTÍNEZ
Investigadora en el periodo 2007-2012
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (6)
2017
-
Phenotype of mutations in the promoter region of the β-globin gene
Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 874-878
2011
-
Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response
Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960
2010
-
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150
-
Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
Annals of Hematology, Vol. 89, Núm. 2, pp. 147-154
2007
-
Hemoglobina Fannin-Lubbock II [β111(G13)Val → Leu y β119(GH2)Gly → Asp]: Descripción de 4 nuevos casos
Medicina Clinica, Vol. 129, Núm. 10, pp. 379-381
2000
-
Hb Johnstown [β109 (G11) Val→Leu]: Second case described and associated for the first time with β0-thalassemia in two Spanish families
American Journal of Hematology, Vol. 65, Núm. 4, pp. 298-301